Cytogenetics of childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council treatment trials AML 10 and 12

Harrison, Christine J., Hills, Robert Kerrin, Moorman, Anthony V., Grimwade, David J., Hann, Ian M., Webb, David K. H., Wheatley, Keith, de Graff, Siebold S. N., van den Berg, Eva, Burnett, Alan K. and Gibson, Brenda E. S. 2003. Cytogenetics of childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council treatment trials AML 10 and 12. Blood -New York- 102 (11) , 98A-98A.

Full text not available from this repository.

Abstract

Karyotype is an independent indicator of prognosis in acute myeloid leukemia (AML) that is widely applied to risk-adapted therapy. Because AML is rare in children, the true prognostic significance of individual chromosomal abnormalities in this age group remains unclear

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General) R Medicine > RB Pathology
Publisher:	American Society of Hematology
ISSN:	0006-4971
Related URLs:	http://jco.ascopubs.org/content/28/16/26...
Last Modified:	19 Oct 2019 02:53
URI:	http://orca-mwe.cf.ac.uk/id/eprint/49713

Citation Data

Cited 129 times in Google Scholar. View in Google Scholar

Actions (repository staff only)

Edit Item